speb/financial-data huggingface dataset:
CMCSA balance_sheet (annual, 2024-12-31) — Properties: 0.00
CMCSA balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CMCSA cash_flow (annual, 2024-12-31) — Purchase Of Business: -235000000.00
CMCSA cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -2949000000.00
CMCSA cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1082000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Receivables: 13661000000.00
CMCSA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 37025000000.00
CMCSA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 14802000000.00
CMCSA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3573000000.00
CMCSA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -9103000000.00
CMCSA cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -2183000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Retained Earnings: 56972000000.00
CMCSA cash_flow (annual, 2024-12-31) — Sale Of Business: 771000000.00
CMCSA cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
CMCSA income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 8073000000.00
CMCSA income_statement (annual, 2024-12-31) — Selling General And Administration: 8073000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Share Issued: 4660537420.00
CMCSA income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CMCSA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1288000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 85560000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Tangible Book Value: -70146000000.00
CMCSA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -46950000.00
CMCSA income_statement (annual, 2024-12-31) — Tax Provision: 2796000000.00
CMCSA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
CMCSA balance_sheet (annual, 2024-12-31) — Total Assets: 266211000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Capitalization: 179746000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Debt: 99093000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 86274000000.00
CMCSA income_statement (annual, 2024-12-31) — Total Expenses: 100433000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 179937000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 239402000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 140356000000.00
CMCSA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 23297000000.00
CMCSA income_statement (annual, 2024-12-31) — Total Unusual Items: -313000000.00
CMCSA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -313000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 872791028.00
CMCSA balance_sheet (annual, 2024-12-31) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (annual, 2024-12-31) — Working Capital: -12780000000.00
CMCSA income_statement (quarterly, 2025-03-31) — +Operating Expense: 15813000000.00
CMCSA income_statement (quarterly, 2025-03-31) — +Total Revenue: 29887000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11545000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 12881000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -60145000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 37832000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -722000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Amortization: 1618000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1618000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1618000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 1618000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3744297368.00
CMCSA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.90
CMCSA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 7377000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2874000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -2252000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 46000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8593000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8593000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -1224000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4076000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2959000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 8295000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -123000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -327000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -35000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Change In Receivables: 935000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 450000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1261000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Common Stock: 46000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -1224000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 86638000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -2240000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 8415000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 11000000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Assets: 27314000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Debt: 6848000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6848000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 12933000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3766000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 42325000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -43000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Deferred Tax: -43000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Depreciation: 2231000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3849000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 3849000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3849000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3849000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 2231000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3784000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.89
CMCSA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3375000000.00
CMCSA income_statement (quarterly, 2025-03-31) — EBIT: 5542000000.00
CMCSA income_statement (quarterly, 2025-03-31) — EBITDA: 9391000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -194000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 14000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — End Cash Position: 8652000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4075000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 5420000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -24000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1197000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Goodwill: 59094000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 156176000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 13603000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 123437000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Gross Profit: 21472000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Interest Expense: 1050000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1050000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 185760000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2958000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 8524000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 92274000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 92274000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CMCSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -636000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 662000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Minority Interests: 79000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 41000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -2240000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Net Debt: 90529000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income: 3375000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3375000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3296000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3375000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3375000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 3296000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3296000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -622000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Interest Income: -1050000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -145000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -636000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -636000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1050000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 25000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 20000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Net PPE: 63292000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -69538000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 25136000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 25136000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9415000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Normalized Income: 3392609973.29
CMCSA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 8294000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 231000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Operating Income: 5659000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Operating Revenue: 29887000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3744297368.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5840000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: -1000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1197000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Other Income Expense: -116000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 97082000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 129000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 12464000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 20735000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 102000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 9893000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Payables: 11545000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 22545000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CMCSA income_statement (quarterly, 2025-03-31) — Pretax Income: 4492000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -2240000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -2000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -622000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -145000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Receivables: 12881000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 8415000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3849000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -636000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -2240000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 57473000000.00
CMCSA cash_flow (quarterly, 2025-03-31) — Sale Of Business: 43000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2071000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2071000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Share Issued: 4617088396.00
CMCSA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 382000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 86638000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -69538000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -6390026.71
CMCSA income_statement (quarterly, 2025-03-31) — Tax Provision: 1196000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Assets: 267770000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 178912000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Debt: 99122000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 87300000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Total Expenses: 24228000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 180470000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 240456000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 138145000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 5658000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -24000000.00
CMCSA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -24000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 872791028.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2025-03-31) — Working Capital: -15011000000.00
CMCSA income_statement (quarterly, 2025-06-30) — +Operating Expense: 16744000000.00
CMCSA income_statement (quarterly, 2025-06-30) — +Total Revenue: 30313000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 11826000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 13040000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -61311000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 37797000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -732000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Amortization: 1805000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1805000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1805000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 1805000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3697950510.00
CMCSA income_statement (quarterly, 2025-06-30) — Basic EPS: 3.01
CMCSA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 8652000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3313000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -2678000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 46000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 9687000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 9687000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1238000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1805000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -4944000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 7813000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 311000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1275000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 69000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Change In Receivables: 88000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -807000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1064000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Common Stock: 46000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1238000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 96851000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1826000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 7576000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10215000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Assets: 29036000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Debt: 5720000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5720000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 4031000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 4031000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 31792000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 2599000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Deferred Tax: 2599000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Depreciation: 2349000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4154000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 4154000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4154000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 4154000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 2349000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3727000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.98
CMCSA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 11123000000.00
CMCSA income_statement (quarterly, 2025-06-30) — EBIT: 15752000000.00
CMCSA income_statement (quarterly, 2025-06-30) — EBITDA: 19906000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -29000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 32000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — End Cash Position: 9748000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1806000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4502000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 136000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 525000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Goodwill: 61812000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 158429000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 13772000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 125336000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Gross Profit: 22737000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Interest Expense: 1105000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1105000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 198379000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -4945000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 8463000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2494000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 95808000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 95808000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 2494000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1220000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 607000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Minority Interests: 79000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -664000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1826000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Net Debt: 91841000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income: 11123000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 11123000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 11044000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 11123000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 11123000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 11044000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11044000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -635000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Interest Income: -1105000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -987000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 1274000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1274000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1105000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -16000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 19000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Net PPE: 64025000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -61578000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 27692000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 27692000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 19770000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Normalized Income: 11020454495.80
CMCSA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 7815000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -9621000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Operating Income: 5993000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Operating Revenue: 30313000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 3697950510.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6309000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 525000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Other Income Expense: 9759000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 96617000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 125000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 13897000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 21100000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 9652000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 10422000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Payables: 11826000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 22041000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CMCSA income_statement (quarterly, 2025-06-30) — Pretax Income: 14647000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -1826000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1280000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -635000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -987000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Receivables: 13040000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 7576000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4154000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1220000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1826000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 66000000000.00
CMCSA cash_flow (quarterly, 2025-06-30) — Sale Of Business: 616000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2168000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2168000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Share Issued: 4570741538.00
CMCSA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 321000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 96851000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -61578000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 33454495.80
CMCSA income_statement (quarterly, 2025-06-30) — Tax Provision: 3603000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Assets: 273850000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 192659000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Debt: 101528000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 97458000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Total Expenses: 24320000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 176392000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 244814000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 144600000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 5992000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Total Unusual Items: 136000000.00
CMCSA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 136000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 872791028.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2025-06-30) — Working Capital: -2756000000.00
CMCSA income_statement (quarterly, 2025-09-30) — +Operating Expense: 17010000000.00
CMCSA income_statement (quarterly, 2025-09-30) — +Total Revenue: 31198000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 11689000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 13213000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -61772000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 37768000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -817000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Amortization: 1666000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1666000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1666000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 1666000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3654514503.00
CMCSA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.91
CMCSA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 9748000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3748000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -3071000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 45000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9325000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 9325000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1223000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -5243000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3816000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 8693000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -356000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1036000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -169000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -307000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 204000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Changes In Cash: -366000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Common Stock: 45000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -1223000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 97081000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1552000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8655000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 10942000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Assets: 28857000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Debt: 5852000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5852000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 4218000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 4218000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 32702000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 694000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 694000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Depreciation: 2354000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 4020000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 4019000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 4020000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 4019000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 2353000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3689000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.90
CMCSA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3332000000.00
CMCSA income_statement (quarterly, 2025-09-30) — EBIT: 5596000000.00
CMCSA income_statement (quarterly, 2025-09-30) — EBITDA: 9616000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -90000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -11000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — End Cash Position: 9371000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -5243000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4945000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 152000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -90000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Goodwill: 61406000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 157109000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 14030000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 126545000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Gross Profit: 22543000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Interest Expense: 1128000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1128000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 196144000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3817000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 8324000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 93211000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 93211000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CMCSA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2510000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 555000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Minority Interests: 83000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -15000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1552000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Net Debt: 89738000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income: 3332000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3332000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3250000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3332000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3332000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3250000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3249000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -677000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Interest Income: -1128000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -94000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -2510000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -2510000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1128000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 42000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 40000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Net PPE: 64773000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -60028000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 28357000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 28357000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 9464000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Normalized Income: 3221435989.26
CMCSA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 8693000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 108000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Operating Income: 5533000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Operating Revenue: 31198000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3654514503.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6319000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -90000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Other Income Expense: 62000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 95703000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 106000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 13932000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 21089000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 10795000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Payables: 11689000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 22631000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CMCSA income_statement (quarterly, 2025-09-30) — Pretax Income: 4468000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -1552000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CMCSA cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -677000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -94000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Receivables: 13213000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8654000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 4020000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2510000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1552000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 66875000000.00
CMCSA cash_flow (quarterly, 2025-09-30) — Sale Of Business: -15000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2196000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2196000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Share Issued: 4527305531.00
CMCSA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 311000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 97081000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -60028000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 41435989.26
CMCSA income_statement (quarterly, 2025-09-30) — Tax Provision: 1218000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Assets: 272995000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 190292000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Debt: 99063000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 97636000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Total Expenses: 25665000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 175359000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 244138000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 142657000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 5534000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Total Unusual Items: 152000000.00
CMCSA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 152000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 872791028.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 7517000000.00
CMCSA balance_sheet (quarterly, 2025-09-30) — Working Capital: -3845000000.00
CMCSA income_statement (annual, 2025-12-31) — +Operating Expense: 68086000000.00
CMCSA income_statement (quarterly, 2025-12-31) — +Operating Expense: 18519000000.00
CMCSA income_statement (annual, 2025-12-31) — +Total Revenue: 123707000000.00
CMCSA income_statement (quarterly, 2025-12-31) — +Total Revenue: 32310000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Accounts Payable: 11058000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11058000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 13869000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 13869000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -60800000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -60800000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 37709000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 37709000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -713000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -713000000.00
CMCSA income_statement (annual, 2025-12-31) — Amortization: 6884000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Amortization: 1795000000.00
CMCSA cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 6884000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1795000000.00
CMCSA cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 6884000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1795000000.00
CMCSA income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 6884000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 1795000000.00
CMCSA income_statement (annual, 2025-12-31) — Basic Average Shares: 3604212627.00
CMCSA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3604212627.00
CMCSA income_statement (annual, 2025-12-31) — Basic EPS: 5.55
CMCSA income_statement (quarterly, 2025-12-31) — Basic EPS: 0.60
CMCSA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 7377000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9371000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 26900000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 26900000000.00
CMCSA cash_flow (annual, 2025-12-31) — Capital Expenditure: -14408000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4473000000.00
CMCSA cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -11750000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -3749000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Capital Stock: 45000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 45000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9481000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9481000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9481000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9481000000.00
CMCSA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -4894000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1209000000.00
CMCSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -14345000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3221000000.00
CMCSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -16158000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4439000000.00
CMCSA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 33644000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 8843000000.00
CMCSA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 338000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 506000000.00
CMCSA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 1994000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 2560000000.00
CMCSA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -20000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 115000000.00
CMCSA cash_flow (annual, 2025-12-31) — Change In Receivables: -135000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Change In Receivables: -851000000.00
CMCSA cash_flow (annual, 2025-12-31) — Change In Working Capital: 2177000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2330000000.00
CMCSA cash_flow (annual, 2025-12-31) — Changes In Cash: 3140000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1181000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Common Stock: 45000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Common Stock: 45000000.00
CMCSA cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -4894000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1209000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 96903000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 96903000000.00
CMCSA cash_flow (annual, 2025-12-31) — Common Stock Payments: -7155000000.00
CMCSA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1537000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Construction In Progress: 2400000000.00
CMCSA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2400000000.00
CMCSA income_statement (annual, 2025-12-31) — Cost Of Revenue: 34951000000.00
CMCSA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10305000000.00
CMCSA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 12410000000.00